FDA Accelerated Approval of First Immunotherapy for treating Metastatic Breast Cancer

Breast Cancer Ireland supports Susan G. Komen – the largest breast cancer organisation in the US – in applauding the decision by the US FDA to provide accelerated approval of a new therapy to treat locally advanced or metastatic triple-negative breast cancer in certain patients.

To read more on this development, please click the link below:

https://ww5.komen.org/News/Komen-Applauds-FDA-Approval.html?fbclid=IwAR3bJHtmrX430XC9ZN2z1MOnTraQ7f9MYjjTGjjDilWjaZQ7nXnjqJe3g6M

 

Share This Article

X